News and key milestones

Medical Doctor -magazine (Lääkärilehti) covered GlucoModicum in their latest issue

GlucoModicum completes successful pilot clinical trials

GlucoModicum completes industrial grade prototype and sensor

GlucoModicum Clinical Trial raises a lot of interest

GlucoModicum closes the next funding round

Valvira approves Pilot Clinical Trials to evaluate GlucoModicum’s needle-free glucose monitor on Type 2 Diabetics in Finland

Glucomodicum selected as one of the top 40 early-stage health tech companies in Europe

GlucoModicum has closed +1,2MEUR Seed Round

GlucoModicum closes Pre-Seed funding round

GlucoModicum Ltd is established.

GlucoModicum – Health Design 2017 Winner.